Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
359.6 INR | +0.28% |
|
-5.90% | -11.50% |
06-13 | Venus Remedies Bags Tender from UNICEF for Antibiotic Ceftriaxone | MT |
05-30 | Venus Remedies Limited Reports Earnings Results for the Fourth Quarter and Full Year Ended March 31, 2024 | CI |
Sales 2022 | 5.99B 71.78M 98.23M | Sales 2023 | 5.56B 66.61M 91.15M | Capitalization | 2.16B 25.96M 35.52M |
---|---|---|---|---|---|
Net income 2022 | 407M 4.88M 6.68M | Net income 2023 | 266M 3.19M 4.36M | EV / Sales 2022 | 0.6 x |
Net cash position 2022 | 4.11M 49.24K 67.38K | Net cash position 2023 | 291M 3.48M 4.77M | EV / Sales 2023 | 0.34 x |
P/E ratio 2022 |
8.71
x | P/E ratio 2023 |
8.15
x | Employees | 998 |
Yield 2022 * |
-
| Yield 2023 |
-
| Free-Float | 52.78% |
1 day | +0.28% | ||
1 week | -5.90% | ||
Current month | +0.28% | ||
1 month | +13.66% | ||
3 months | +6.27% | ||
6 months | -11.24% | ||
Current year | -11.50% |
![Extreme 346](/images/extremecours_fleche.png)
![Extreme 290.2](/images/extremecours_fleche.png)
![Extreme 281.1](/images/extremecours_fleche.png)
![Extreme 222](/images/extremecours_fleche.png)
![Extreme 145.8](/images/extremecours_fleche.png)
![Extreme 18.8](/images/extremecours_fleche.png)
![Extreme 18.8](/images/extremecours_fleche.png)
Managers | Title | Age | Since |
---|---|---|---|
Ashutosh Jain
CEO | Chief Executive Officer | 47 | 07-04-30 |
Pawan Chaudhary
CHM | Chairman | 60 | 89-09-14 |
Jitendra Singh
ADM | Chief Administrative Officer | - | 98-12-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Gilbert Wenzel
BRD | Director/Board Member | 68 | - |
Peeyush Jain
BRD | Director/Board Member | 52 | - |
Ashutosh Jain
CEO | Chief Executive Officer | 47 | 07-04-30 |
Date | Price | Change | Volume |
---|---|---|---|
24-07-01 | 359.6 | +0.28% | 46 381 |
24-06-28 | 358.6 | +2.62% | 66,405 |
24-06-27 | 349.4 | -4.67% | 95,295 |
24-06-26 | 366.5 | -1.94% | 55,639 |
24-06-25 | 373.8 | -2.19% | 39,088 |
Delayed Quote NSE India S.E., July 01, 2024 at 06:21 am
More quotes1st Jan change | Capi. | |
---|---|---|
+55.32% | 815B | |
+42.97% | 641B | |
-6.75% | 352B | |
+13.56% | 314B | |
+10.68% | 303B | |
+16.19% | 242B | |
+2.17% | 224B | |
+13.34% | 218B | |
+8.48% | 168B |
- Stock Market
- Equities
- VENUSREM Stock
- VENUSREM Stock